Growth factor-sensitive molecular targets identified in primary and metastatic head and neck squamous cell carcinoma using microarray analysis.
Polypeptide growth factors play key roles in the processes of cell migration and invasion. In this study, we have used cDNA microarrays to identify target genes whose expression is differentially modulated by the growth factors TGFbeta and EGF. HN4 and HN12 cell lines, established from primary tumor and a lymph node metastasis arising in one patient with head and neck squamous cell carcinoma, were treated with 2nM EGF or 50pM TGFbeta for 24h and extracted RNA was used to prepare labeled cDNAs which were hybridized to NCI UniGem 2.0 cDNA microarrays containing 9128 features. Results revealed constitutive overexpression of 41 genes and underexpression of 109 genes in metastatic HN12 compared to HN4 under conditions of serum withdrawal. Furthermore, TGFbeta treatment resulted in relative upregulation of 53 genes and downregulation of 91 genes in HN12 compared with HN4, whereas cells treated with EGF showed relative upregulation of 67 genes and downregulation of 113 genes. Partial overlap was found between TGFbeta and EGF-modulated gene sets. Results were verified for a subset of each category using quantitative PCR, western blotting and zymography. The data indicate that TGFbeta and EGF differentially affect gene expression in primary and metastatic HNSCC cells, and likely contribute to the invasive properties of metastatic cells through regulation of both common and specific mediators for each growth factor.
Miyazaki
Hiroshi
H
Philips Institute of Oral and Craniofacial Molecular Biology, School of Dentistry, Virginia Commonwealth University, P.O. Box 980566, Room 424, 521 N. 11th Street, Richmond, VA 23298-0566, USA.
Patel
Vyomesh
V
Wang
Huixin
H
Ensley
John F
JF
Gutkind
J Silvio
JS
Yeudall
W Andrew
WA
D015153:Blotting, Western; D002294:Carcinoma, Squamous Cell / Q000235:genetics* / Q000556:secondary; D045744:Cell Line, Tumor; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D005434:Flow Cytometry; D015870:Gene Expression / Q000187:drug effects*; D006258:Head and Neck Neoplasms / Q000235:genetics*; D006801:Humans; D046228:Microarray Analysis / Q000379:methods*; D009361:Neoplasm Invasiveness; D010641:Phenotype; D016133:Polymerase Chain Reaction / Q000379:methods; D015398:Signal Transduction; D016212:Transforming Growth Factor beta / Q000235:genetics / Q000494:pharmacology*
D016212:Transforming Growth Factor beta; D004815:Epidermal Growth Factor